Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward ...
MassDevice2h
Stryker completes acquisition of Inari Medical
“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said ...
Zacks.com on MSN14d
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
Inari Medical stock soars to 52-week high of $79.95
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.95. According to InvestingPro analysis, the company, now valued at $4.69 billion, shows signs of being slightly ...
Kadant to replace Inari Medical in S&P 600 at open on 2/19
Kadant (KAI) will replace Inari Medical (NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19.
Becker's Spine Review25m
Stryker completes Inari Medical acquisition
Stryker completed its acquisition of Inari Medical, the devicemaker said Feb. 19. The companies entered into a definitive agreement for the $4.9 billion acquisition in January. The deal will support ...